ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$6.18 USD
-0.09 (-1.44%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $6.19 +0.01 (0.16%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | -25.00% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.75 |
Next Year | -0.52 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.53M | 10.03M | 71.56M | 277.39M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 2.53M | 10.03M | 107.80M | 308.20M |
Low Estimate | 2.53M | 10.03M | 35.31M | 246.57M |
Year ago Sales | 0.04M | 0.08M | 0.62M | 71.56M |
Year over Year Growth Est. | 6,212.50% | 12,431.25% | 11,404.37% | 287.65% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.16 | -0.75 | -0.52 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.17 | -0.16 | -0.65 | -0.42 |
Low Estimate | -0.17 | -0.16 | -0.84 | -0.62 |
Year ago EPS | -0.28 | -0.19 | -0.99 | -0.75 |
Year over Year Growth Est. | 39.29% | 15.79% | 24.24% | 30.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.16 | -0.75 | -0.52 |
7 Days Ago | -0.17 | -0.16 | -0.75 | -0.52 |
30 Days Ago | -0.17 | -0.16 | -0.75 | -0.52 |
60 Days Ago | -0.17 | -0.17 | -0.76 | -0.54 |
90 Days Ago | -0.17 | -0.17 | -0.68 | -0.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.16 | -0.75 | -0.52 |
Zacks Consensus Estimate | -0.17 | -0.16 | -0.75 | -0.52 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.19 | -0.19 | -0.28 | NA |
Estimate | -0.16 | -0.18 | -0.27 | -0.26 | NA |
Difference | -0.04 | -0.01 | 0.08 | -0.02 | 0.00 |
Surprise | -25.00% | -5.56% | 29.63% | -7.69% | -2.16% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more